GeoWealth | $38,000,000 | (Aug 5, 2025)
Afaxys, Inc. | $8,000,000 | (Aug 5, 2025)
Comp AI | $2,600,000 | (Aug 5, 2025)
Certified by Founder
Lodge
Tome Biosciences
start up
United States
- Watertown, Massachusetts
- 14/12/2023
- Series B
- $213,000,000
Tome Biosciences is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific precision. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies.
- Industry Biotechnology Research
- Website https://tome.bio/
- LinkedIn https://www.linkedin.com/company/tome-biosciences/about/
Jeh Aerospace | $11,000,000 | (Aug 5, 2025)
Conversion | $28,000,000 | (Aug 5, 2025)
Approov Mobile Security | $6,641,429 | (Aug 5, 2025)
Q.ANT | $71,676,650 | (Aug 5, 2025)
BioConsortia, Inc. | $15,000,000 | (Aug 5, 2025)
Bidbus | $3,300,000 | (Aug 5, 2025)
Blue J | $122,000,000 | (Aug 5, 2025)
Deep Cogito | $13,000,000 | (Aug 5, 2025)
Streamline AI | $8,600,000 | (Aug 5, 2025)